Cite
APA Citation
Guo, X., Wang, S., Bay-Jensen, A., Karsdal, M., Godwood, A., Close, D., Ryan, P., Roskos, L., & White, W. (n.d.). oP0244 Sustained Suppression of Rheumatoid Arthritis Disease Markers by Mavrilimumab but Not Golimumab in Anti-Tumor Necrosis Factor-Inadequate Responders: An Exploratory Analysis in The Phase IIB Earth Explorer 2 Clinical Trial. Annals of the rheumatic diseases, 75, 150–151. http://access.bl.uk/ark:/81055/vdc_100135163150.0x000051